Clinical efficacy and safety profile of long-acting lipoglycopeptides versus daily intravenous antibiotics for acute bacterial skin and skin structure infections (ABSSSI): a retrospective study in Greece

JOURNAL OF CHEMOTHERAPY · Published 2026-08-03 · DOI 10.1080/1120009x.2026.2710944

Authors (10)

Vasileios Petrakis, Andreas G. Tsantes, Petros Rafailidis, Maria Panopoulou, Touba Bougiouklou, Georgios Karagiannis, Anastasia Sousanidou, Nikoleta Babaka, Dimitrios Papazoglou, Periklis Panagopoulos

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Petrakis, V., Tsantes, A., Rafailidis, P., et al. (2026). Clinical efficacy and safety profile of long-acting lipoglycopeptides versus daily intravenous antibiotics for acute bacterial skin and skin structure infections (ABSSSI): a retrospective study in Greece. JOURNAL OF CHEMOTHERAPY. https://doi.org/10.1080/1120009x.2026.2710944

Related articles

• Dalbavancin to facilitate early discharge in the treatment of complex musculoskeletal infections: a multi-centre real-life application · Journal of Bone and Joint Infection · 2025 · Cites or is cited by this article
• Efficacy and clinical potential of phage therapy in treating methicillin-resistant Staphylococcus aureus (MRSA) infections: A review · European Journal of Microbiology and Immunology · 2024 · Cites or is cited by this article
• The impact of low-volume hydration on kidney function in low-dose cisplatin therapy for biliary tract cancer: a multicentre retrospective cohort study · JOURNAL OF CHEMOTHERAPY · 2026 · Same journal
• Pharmacokinetic/pharmacodynamic optimization of antimicrobial therapy in neutropenic sepsis: a comprehensive review · JOURNAL OF CHEMOTHERAPY · 2026 · Same journal
• Successful remdesivir treatment of coronavirus OC43 pneumonia in a lung transplant recipient · JOURNAL OF CHEMOTHERAPY · 2025 · Same journal
• A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer · JOURNAL OF CHEMOTHERAPY · 2025 · Same journal
• A 1:1:1 propensity score matching design to account for center-specific antimicrobial treatment or prophylaxis in observational studies: the case of the POSACOVID study · JOURNAL OF CHEMOTHERAPY · 2026 · Same journal
• Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease · JOURNAL OF CHEMOTHERAPY · 2025 · Same journal
• The role of gut microbiome in chemoresistance property development in colorectal cancer tissue and its novel therapeutic strategies · JOURNAL OF CHEMOTHERAPY · 2026 · Same journal
• The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study · JOURNAL OF CHEMOTHERAPY · 2025 · Same journal